S |
2010-02-16 13:28:08.0 |
VIA Pharmaceuticals |
VIAP |
Xmark Opportunity Partners |
0.0% |
view |
B |
2009-02-17 08:20:40.0 |
VIA Pharmaceuticals |
VIAP |
Xmark Opportunity Partners |
8.5% |
view |
S |
2009-02-10 16:36:37.0 |
VIA Pharmaceuticals |
VIAP |
Enable Growth Partners L P |
4.8% |
view |
S |
2009-02-10 16:32:35.0 |
VIA Pharmaceuticals |
VIAP |
Enable Capital Management |
4.8% |
view |
B |
2008-07-30 17:25:02.0 |
VIA Pharmaceuticals |
VIAP |
Enable Growth Partners L P |
8.4% |
view |
B |
2008-07-30 17:20:40.0 |
VIA Pharmaceuticals |
VIAP |
Enable Capital Management |
8.4% |
view |
S |
2008-02-14 10:02:26.0 |
VIA Pharmaceuticals |
VIAP |
Xmark Opportunity Partners |
7.2% |
view |
B |
2007-08-14 17:18:17.0 |
VIA Pharmaceuticals |
VIAP |
Xmark Opportunity Partners |
7.6% |
view |
B |
2006-03-21 00:00:00.0 |
CORAUTUS GENETICS INC |
CAQ |
ARDSLEY ADVISORY PARTNERS |
6.12% |
view |
S |
2006-02-15 00:00:00.0 |
CORAUTUS GENETICS INC |
CAQ |
ARDSLEY ADVISORY PARTNERS |
3.88% |
view |
S |
2005-02-11 00:00:00.0 |
CORAUTUS GENETICS INC |
CAQ |
ARDSLEY ADVISORY PARTNERS |
5.2% |
view |
S |
2004-02-12 00:00:00.0 |
CORAUTUS GENETICS INC |
CAQ |
ARIES FINANCIAL SERVICES INC |
7.31% |
view |
B |
2004-01-29 00:00:00.0 |
CORAUTUS GENETICS INC |
CAQ |
ARDSLEY ADVISORY PARTNERS |
9.9% |
view |
B |
2003-02-14 00:00:00.0 |
CORAUTUS GENETICS INC |
CAQ |
HUMAN GENOME SCIENCES INC |
17.5% |
view |
S |
2002-09-20 00:00:00.0 |
GENSTAR THERAPEUTICS CORP |
CAQ |
BAXTER INTERNATIONAL INC |
31.0% |
view |
S |
2002-03-12 00:00:00.0 |
GENSTAR THERAPEUTICS CORP |
CAQ |
BAXTER INTERNATIONAL INC |
31.0% |
view |
B |
2002-03-06 00:00:00.0 |
GENSTAR THERAPEUTICS CORP |
CAQ |
BAXTER INTERNATIONAL INC |
40.5% |
view |
B |
2001-02-05 00:00:00.0 |
GENSTAR THERAPEUTICS CORP |
CAQ |
ROYSTON IVOR |
11.0% |
view |
B |
2000-03-08 00:00:00.0 |
UROGEN CORP |
CAQ |
ARIES FINANCIAL SERVICES INC |
25.2% |
view |
B |
2000-01-27 00:00:00.0 |
UROGEN CORP |
CAQ |
ARIES FINANCIAL SERVICES INC |
17.3% |
view |
B |
1997-02-14 00:00:00.0 |
UROGEN CORP |
CAQ |
KIMMEL SYNDEY CANCER CENTER |
5.6% |
view |